4.99K
·
2025-08-18
🏆 Award-Winning Trader Interview | @FFreedom_in_10y: Maximizing Gains, Managing Risk
As a healthcare professional with 15 years of U.S. market investing under his belt—evolving from common stocks to sophisticated options—@FFreedom in 10y combined fundamental insights and tactical adjustments to clinch victory in this competition.[Miser][Miser]🔥🔥🥳🥳[Smart][Smart]🔍 Strategy & ExecutionProfit Maximization & Risk Minimization 💹“My core goal: maximize profit while minimizing risk. I adjust positions dynamically in response to market changes.”Options Expertise Transitioning from stocks to primarily trading options, he leveraged short puts and covered calls to enhance returns.⚖️ Risk Management & PositioningLiquidity & Buying Power Mastery “The biggest challenge was tracking my liquidity and buying power—seizin
TOP1PC: Congratulations 🎉👏 Nice Sharing 🎊👏 @JC888 @Jes86188 @Barcode @koolgal @Shernice軒嬣 2000 @Shyon
6.02K
·
2025-08-19
$XJO Hits ATH after Rate Cut: Macro Drivers,Top Performers & Earnings Preview
1. $S&P/ASX 200(XJO.AU)$ Hit All Time High on MondayThe $S&P/ASX 200(XJO.AU)$ has reached multiple all-time highs in 2025, driven by sector rotation and optimism around monetary policy, with Materials, Technology, and Utilities leading recent gains.Below are the star ASX companies by returns in 2025: $MEDIBANK PRIVATE LTD(MPL.AU)$ , $QANTAS AIRWAYS LIMITED(QAN.AU)$ , $ORICA LTD(ORI.AU)$ , $WESFARMERS LTD(WES.AU)$ , $GPT GROUP(GPT.AU)$ ,
TOPGreat insights! I'm excited to see how these top performers will fare in the upcoming earnings.
4.81K
·
2025-08-19
Estée Lauder (EL) 13F Movement By Burry Might Mean Post Earnings Positive Signal
$Estee Lauder(EL)$ is scheduled to release its fiscal Q4 2025 earnings before the market opens on August 20, 2025. Estée Lauder (EL), which is down over 80% from its peak of $350 to $69, is showing signs of a potential turnaround. Based on he 13F filing, we can see that despite its decline, it is the only remaining stock in Michael Burry’s 13F portfolio, and recent activity such as sizable January 2027 $110 call purchases and insider buying near current levels, these suggests renewed investor confidence. Overall Revenue : Analysts are expecting a decline in both the top and bottom lines for Q4. The Zacks consensus estimate for revenue is approximately $3.4 billion, representing a drop of over 12% year-over-year. Overall Earnings Per Share (EPS) : Th
TOPAny insight for this?😂as far as I know, this stock drop a lot due to poor sale in China and the stock have been hovering between 85 to 95. So what is the recovery plan to increase the sale to pump the share price?
2.65K
·
2025-08-19
Xiaomi Earnings Preview: Positioned for a Consumption-Led Upswing?
$Xiaomi Corp.(XIACY)$ Xiaomi sits at a crossroads. After a blistering run driven by a surprise acceleration in revenues, excitement around its electric-vehicle (EV) push and durable gains in smartphone share across several emerging markets, the company will report interim results on August 19, 2025 — a data point investors are treating as a test of whether the recent momentum is sustainable or merely a cyclical uptick in a fragile Chinese consumption backdrop. This preview examines the performance drivers, how the market has already priced recent wins, what the balance sheet and cash flow say about downside protection, and whether today's multiple leaves room for further upside if consumption truly re-accelerates. Performance overview and market
TOPXiaomi’s EV & services! Holding tight, betting on the upside.
4.66K
·
2025-08-19
Burry's 13F - Bullish Bets on 6 US stocks.
It was back in 21 May 2025 that I have posted about Michael Burry’s latest 13-F filing revealing there was all but one stock left in his holdings. Click here ! to refresh your memory. Fast forward 3 months later, here we are again with the latest on his company Scion Asset Management latest filings for Q2 2025. Latest Purchase. His firm has significantly increased exposure to both equity & options in: Healthcare. Discretionary. Tech. At the same time, the fund also closed out of some bearish “Put” options in several big Chinese tech stocks and also $NVIDIA(NVDA)$. Analysts said that Burry has shifted to a more optimistic outlook on the market and betting on stocks like: $
TOPAvoid new stocks 😕.... I will try some when TA meets New Stock [Chuckle] @Barcode @Jes86188 @koolgal @Shernice軒嬣 2000 @Shyon
2.76K
·
2025-08-19
The Central Bank Annual Meeting Approaches: Focus on Powell’s Rate Cut Remarks
Last Friday’s US-Russia talks failed to produce any “decisive” outcomes. The United States still requires coordination with the European Union and Ukraine for further discussions. Therefore, the Russia-Ukraine conflict is unlikely to end in the short term. However, the secondary sanctions on purchasing Russian crude oil are expected to ease somewhat. This outcome was largely anticipated by the market, so it did not cause significant surprise. Looking ahead to next week, the key focus will be whether there are confirmed plans for trilateral talks involving the US, Russia, and Ukraine.Additionally, starting next Wednesday, the World Central Banks Annual Meeting will be held over three days. Market attention will center on the Federal Reserve Chairman’s speech at this event. Given Jerome Powe
4.14K
·
2025-08-19
$INNOVENT BIO(01801)$ Innovent's biotech dominance showing! PD-1 global expansion + bispecific pipeline = home run. Clinical milestones ahead - this is a long-term keeper!
4.23K
·
2025-08-19
$CTIHK(06055)$ While the bull market parties, China Tobacco HK chills like a 'Zen stock'. It saved portfolios multiple times during H1 slumps—a true safe-haven play. Patience! Its monopoly license + state-backed moat will lure smart money soon.
4.86K
·
2025-08-19
$ProShares UltraPro Short QQQ(SQQQ)$ 's 3x Nasdaq short pays off! Tech valuation squeeze + rate fears = perfect bear play. But stay alert for bounce backs - taking profits strategically!
4.64K
·
2025-08-19
$-1X Short VIX Futures ETF(SVIX)$ volatility short works like a charm! Fear index declining smoothly - perfect for this inverse play. But remember to take profits before the tide turns!
5.11K
·
2025-08-19
$MARA Holdings(MARA)$ consolidates with positive momentum today. A bullish "inside bar" pattern emerges alongside volume surge to 50M shares. Breaking out soon? Patience pays.
4.18K
·
2025-08-19
$Trade Desk Inc.(TTD)$ 's programmatic ad dominance prevails! AI-powered targeting + industry recovery = patient investors rewarded. Quality compounders always win in the long run!
3.86K
·
2025-08-19
$Bilibili Inc.(BILI)$ Next gem for BILI? Video podcasts! Proven overseas, BILI's combo of mid-length videos+lightweight creation fits perfectly. GenZ users are already locked in.
4.62K
·
2025-08-19
$Novo-Nordisk A/S(NVO)$ 's weight-loss dominance continues! GLP-1 craze + capacity boost, but rich valuation calls for caution - taking partial profits and waiting for pullback!
4.18K
·
2025-08-19
$Tempus AI(TEM)$ "Blue-chip stocks" flexing muscles again! When these dream stocks like TEM rally, they go wild. The US market never lacks opportunities—only disciplined holders.
4.14K
·
2025-08-19
$Lyft, Inc.(LYFT)$ 's volume hints at more than a one-day show. Just a shakeout-hard to crash heavily. Big dip today? Might bounce by tonight or tomorrow!
5.31K
·
2025-08-19
$UnitedHealth(UNH)$ The old master strikes again—Buffett proves why he's the investing legend! His long-term bet on UnitedHealth is playing out perfectly. With the stock breaking key resistance at strong volume and still undervalued at current levels, $400 looks like the next stop. Patience pays off—just wait for the bloom!
57.74K
·
2025-08-19
CSL Plunges 17% – Value Oversold Under the Shadow of Restructuring?
Today, CSL $CSL LIMITED(CSL.AU)$ , the largest healthcare giant on the Australian stock market, released its latest earnings report and announced a major restructuring plan. While the results were broadly in line with expectations, the restructuring still triggered a nearly 17% plunge in the company’s share price on the day. Where is the market panic coming from, and what impact could this restructuring have on the company’s long-term outlook? Source: Google Finance CSL Overview CSL Ltd is Australia’s largest healthcare company and a global leader in biopharma. It’s the flagship stock in the ASX healthcare sector, focusing on the R&D and commercialization of innovative biopharmaceuticals. The company has three main divisions: CSL Behring – s
TOPThanks for sharing! The steep overselling always brings a good point to buy.
3.61K
·
2025-08-14
When I first bought PLTR back in September 2020, it wasn’t through a traditional IPO. Instead, the company chose a Direct Public Offering (DPO) - meaning everyone, you and I included, could buy shares at $ 10 from the beginning. IPO in another way, were mostly bought up by institution, you and I can only buy it when it listed at a higher price. This is why Wall Street hates PLTR. Back then, I don't know much. I only know PLTR is very good in data industry and it was co-founded in 2003 by Peter Thiel (yes, the same Peter Thiel who co-founded PayPal with Elon Musk). Me being a Elon musk believer made me believe in Peter Thiel. The company started out building technology for government and intelligence agencies, but in recent years, its commercial business has exploded—with partnerships in he
TOPYour journey with PLTR is inspiring
5.31K
·
2025-08-19
🚨 📰 🔥💥 $PLTR: Short Seller Under Indictment While Palantir Defines the Intelligence Revolution 💥🔥🚨
$Palantir Technologies Inc.(PLTR)$ 🧭 I believe credibility matters when calling value Andrew Left of Citron Research faces 19 counts including securities fraud and false statements tied to an alleged $16M manipulation scheme; the pre-trial hearing is set for 18Aug25 in Los Angeles. Despite this, Citron promotes a $40 target for Palantir after comparing OpenAI’s reported $500B valuation to the true operating system of AI. They argue $40 still looks expensive. I’m fully convinced that a call issued under this cloud deserves heightened scrutiny. 📊 I’m confident Palantir’s Q2 profile signals scalability Revenue reached $1.004B, up 48.1% year on year. Gross profit was $821.7M with an 81.8% margin. Operating income was $464.4M, up 83.1% year on year, an
TOPThe setup you mapped out between $170 support and the $185/$190 call walls is textbook liquidity framing. I like how you tied it to the Keltner and Bollinger channels because that’s the same structure I’ve been watching in $MSFT. Earnings strength plus technical rhythm is hard to dismiss.